Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Silence Therapeutics Plc - American Depository Share (NQ:SLN)

5.340 -0.270 (-4.81%)
Streaming Delayed Price Updated: 12:30 PM EDT, Aug 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,975
Open 5.640
Bid (Size) 5.280 (1)
Ask (Size) 5.410 (1)
Prev. Close 5.610
Today's Range 5.290 - 5.640
52wk Range 1.970 - 20.48
Shares Outstanding 107,808,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera
From Silence Therapeutics plc
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga

Performance

YTD
-25.7%
-25.7%
1 Month
-6.8%
-6.8%
3 Month
+42.4%
+42.4%
6 Month
-4.8%
-4.8%
1 Year
-68.9%
-68.9%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
From Silence Therapeutics plc
Via Business Wire
Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings)
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Silence Therapeutics Welcomes Tim McInerney to Board of Directors
From Silence Therapeutics plc
Via Business Wire
These stocks are moving in today's pre-market session
Via Chartmill
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
From Silence Therapeutics plc
Via Business Wire
Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings)
Via Benzinga
The Analyst Landscape: 6 Takes On Silence Therapeutics
Via Benzinga
Analyst Scoreboard: 4 Ratings For Silence Therapeutics
Via Benzinga
Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
From Silence Therapeutics plc
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 15
Via Talk Markets
Topics Stocks / Equities
Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025
From Silence Therapeutics plc
Via Business Wire
This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Top 3 Health Care Stocks That May Explode In Q4
Via Benzinga
Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
From Silence Therapeutics plc
Via Business Wire
Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference
From Silence Therapeutics plc
Via Business Wire
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
Via Benzinga
Top 3 Health Care Stocks You'll Regret Missing In Q4
Via Benzinga
Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting
From Silence Therapeutics plc
Via Business Wire
Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
From Silence Therapeutics plc
Via Business Wire
Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference
From Silence Therapeutics plc
Via Business Wire
Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences
From Silence Therapeutics plc
Via Business Wire

Frequently Asked Questions

Is Silence Therapeutics Plc - American Depository Share publicly traded?
Yes, Silence Therapeutics Plc - American Depository Share is publicly traded.
What exchange does Silence Therapeutics Plc - American Depository Share trade on?
Silence Therapeutics Plc - American Depository Share trades on the Nasdaq Stock Market
What is the ticker symbol for Silence Therapeutics Plc - American Depository Share?
The ticker symbol for Silence Therapeutics Plc - American Depository Share is SLN on the Nasdaq Stock Market
What is the current price of Silence Therapeutics Plc - American Depository Share?
The current price of Silence Therapeutics Plc - American Depository Share is 5.340
When was Silence Therapeutics Plc - American Depository Share last traded?
The last trade of Silence Therapeutics Plc - American Depository Share was at 08/06/25 12:30 PM ET
What is the market capitalization of Silence Therapeutics Plc - American Depository Share?
The market capitalization of Silence Therapeutics Plc - American Depository Share is 575.70M
How many shares of Silence Therapeutics Plc - American Depository Share are outstanding?
Silence Therapeutics Plc - American Depository Share has 576M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.